Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ

Revenue (LTM)

$678M

+60.1% YoY

Net Income (LTM)

$59M

+236.6% YoY

Free Cash Flow

$25M

Revenue CAGR (5Y)

+104.8%

Marginsdeclining

FCF$0.0B

Now profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	39	220↑471.2%	270↑22.7%	423↑56.6%	678↑60.1%
Gross Profit	29	197↑570.0%	214↑8.3%	362↑69.5%	370↑2.2%
Operating Income	-157	10↑106.2%	-25↓357.8%	-46↓81.0%	77↑269.3%
Net Income	-158	183↑216.1%	14↓92.3%	-43↓406.7%	59↑236.6%
EBITDA	-154	12↑107.9%	-23↓287.7%	-44↓92.2%	90↑305.9%
EPS Diluted	-2.30	2.60↑213.0%	0.20↓92.3%	-0.60↓400.0%	0.75↑225.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	122	123↑0.2%	108↓12.0%	184↑70.1%	166↓9.8%
Total Current Assets	196	243↑23.7%	276↑13.7%	332↑20.1%	527↑58.9%
Total Assets	233	460↑97.5%	526↑14.5%	581↑10.3%	764↑31.5%
Total Current Liabilities	45	47↑5.0%	64↑35.3%	101↑58.0%	139↑38.3%
Total Liabilities	48	64↑33.0%	87↑37.7%	142↑62.5%	196↑37.9%
Total Equity	185	396↑114.1%	439↑10.8%	438↓0.1%	568↑29.5%
Total Debt	6	6↓2.2%	12↑107.1%	10↓19.6%	9↓3.6%
Net Debt	-116	-117↓0.3%	-96↑18.1%	-174↓81.5%	-156↑10.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-126	6↑104.6%	13↑129.1%	26↑93.1%	26↓0.0%
Capital Expenditure	-20	-0↑99.5%	-0↓23.8%	-0↓113.1%	-0↓0.0%
Free Cash Flow	-147	6↑103.9%	13↑131.0%	25↑92.9%	25↓0.0%
Stock-Based Comp	25	25↓0.2%	27↑8.1%	31↑13.1%	31↓0.0%
Net Change in Cash	8	0↓97.0%	-15↓6124.9%	76↑612.3%	76↓0.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance